H20008
3-Hydroxybenzoic acid
ReagentPlus®, 99%
Synonym(s):
m-Salicylic acid
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
product line
ReagentPlus®
assay
99%
mp
200-203 °C (lit.)
SMILES string
OC(=O)c1cccc(O)c1
InChI
1S/C7H6O3/c8-6-3-1-2-5(4-6)7(9)10/h1-4,8H,(H,9,10)
InChI key
IJFXRHURBJZNAO-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
3-Hydroxybenzoic acid, being a component of structural skeleton of various biologically active small molecules, is used in the synthesis of medicinally important compounds such as tyrosine kinase Tie-2 inhibitor, amyloidogenesis inhibitor, antioxidant and anti-inflammatory agents based on oxadiazole analogs of resveratrol.
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1, 3, 5-triazine Tie-2 kinase inhibitor.
Journal of Medicinal Chemistry, 50(4), 611-626 (2007)
Antioxidant and anti-inflammatory properties of 1, 2, 4-oxadiazole analogs of resveratrol.
Chemico-Biological Interactions, 240, 200-207 (2015)
Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.
Journal of Medicinal Chemistry, 51(2), 260-270 (2007)
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 28(5), 377-384 (2006-06-20)
Solution and solid-state properties of m-hydroxybenzoic acid have been investigated. Two polymorphs were found where the monoclinic modification exhibits a higher stability than the orthorhombic form. The solubility of the monoclinic polymorph was determined between 10 and 50 degrees C
Journal of hazardous materials, 137(1), 324-331 (2006-04-11)
This research is dedicated to determine the rejection ratios of disinfection by-products (DBPs) precursors including resorcinol, phloroglucinol, 3-hydroxybenzoic acid, and tannic acid solution in the presence of calcium by nanofiltration with NF70 membrane. The rejections of these model compounds also
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service